<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Sturge-Weber Syndrome and Secondary Glaucoma - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjYbydbNjqe1d87p-WcQAAAAQ","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Sturge-Weber_Syndrome_and_Secondary_Glaucoma","wgTitle":"Sturge-Weber Syndrome and Secondary Glaucoma","wgCurRevisionId":87694,"wgRevisionId":87694,"wgArticleId":3581,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Sturge-Weber_Syndrome_and_Secondary_Glaucoma","wgRelevantArticleId":3581,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,
"wgRestrictionEdit":[],"wgRestrictionMove":[],"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr",
"pageVariantFallbacks":"en"},"srfFilteredConfig":null,"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init",
"ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Sturge-Weber Syndrome (SWS), also known as encephalotrigeminal angiomatosis, is a congenital neuro-oculocutaneous syndrome that presents at birth.&amp;#91;1&amp;#93; SWS was first reported by Dr. Schirmer in 1860 with later descriptions by Dr. Sturge in 1897 and Dr. Weber in 1922.&amp;#91;2&amp;#93; It is characterized as a part of the neuroectodermal dysplasias, also known as phakomatoses. Unlike other phakomatoses, SWS is not hereditary. The incidence has been reported to be 1 per 50,000 live births and, no racial or sex predilection has been found.&amp;#91;3&amp;#93;&amp;#91;4&amp;#93;"/>
<meta name="date" content="2022-12-24"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Sturge-Weber Syndrome and Secondary Glaucoma" href="/w/index.php?title=Special:ExportRDF/Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Sturge-Weber_Syndrome_and_Secondary_Glaucoma rootpage-Sturge-Weber_Syndrome_and_Secondary_Glaucoma layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Sturge-Weber+Syndrome+and+Secondary+Glaucoma" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Sturge-Weber+Syndrome+and+Secondary+Glaucoma" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzz0eqg2"></button>
					<div class="collapse navbar-collapse hbpzz0eqg2" id="hbpzz0eqg2">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Sturge-Weber_Syndrome_and_Secondary_Glaucoma" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Sturge-Weber_Syndrome_and_Secondary_Glaucoma#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Sturge-Weber Syndrome and Secondary Glaucoma</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Sarwat.Salim.SEC" title="User:Sarwat.Salim.SEC">Sarwat Salim MD, FACS</a>,&#8201;<a href="/User:Walter.Luchsinger" title="User:Walter.Luchsinger">Walter Luchsinger, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Up to Date</b>
</div>
</div>&#160;by <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a> on December 25, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<p>Sturge-Weber Syndrome (SWS), also known as encephalotrigeminal angiomatosis, is a congenital neuro-oculocutaneous syndrome that presents at birth.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1">&#91;1&#93;</a></sup> SWS was first reported by Dr. Schirmer in 1860 with later descriptions by Dr. Sturge in 1897 and Dr. Weber in 1922.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2">&#91;2&#93;</a></sup> It is characterized as a part of the neuroectodermal dysplasias, also known as phakomatoses. Unlike other phakomatoses, SWS is not hereditary. The incidence has been reported to be 1 per 50,000 live births and, no racial or sex predilection has been found.<sup id="cite_ref-:0_3-0" class="reference"><a href="#cite_note-:0-3">&#91;3&#93;</a></sup><sup id="cite_ref-:1_4-0" class="reference"><a href="#cite_note-:1-4">&#91;4&#93;</a></sup> 
</p><p>SWS can be classified as trisymptomatic when the skin, eye, and central nervous system (CNS) are affected; bisymptomatic when the skin and CNS or the skin and eye are affected; and monosymptomatic when the skin or the CNS is affected.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">&#91;5&#93;</a></sup> The typical triad consists of facial capillary malformation (port wine stain or nevus flammeus), an ipsilateral vascular anomaly in the brain (leptomeningeal hemangioma), and ocular hemangioma.<sup id="cite_ref-:2_6-0" class="reference"><a href="#cite_note-:2-6">&#91;6&#93;</a></sup>
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Cutaneous_Manifestations_and_Treatment"><span class="tocnumber">1</span> <span class="toctext">Cutaneous Manifestations and Treatment</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Neurologic_Manifestations_and_Treatment"><span class="tocnumber">2</span> <span class="toctext">Neurologic Manifestations and Treatment</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Ocular_Manifestations_and_Treatment"><span class="tocnumber">3</span> <span class="toctext">Ocular Manifestations and Treatment</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Glaucoma"><span class="tocnumber">4</span> <span class="toctext">Glaucoma</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Klippel-Trenaunay-Weber_Syndrome_.28KTS.29"><span class="tocnumber">5</span> <span class="toctext">Klippel-Trenaunay-Weber Syndrome (KTS)</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Summary"><span class="tocnumber">7</span> <span class="toctext">Summary</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Cutaneous_Manifestations_and_Treatment">Cutaneous Manifestations and Treatment</span></h1>
<p>The most common type of vascular malformation is port wine stain (PWS), with an overall incidence of 0.3% in live births.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">&#91;7&#93;</a></sup> The incidence of SWS in patients with a PWS has been reported to be between <sup id="cite_ref-:0_3-1" class="reference"><a href="#cite_note-:0-3">&#91;3&#93;</a></sup><sup id="cite_ref-:1_4-1" class="reference"><a href="#cite_note-:1-4">&#91;4&#93;</a></sup> and 5%.<sup id="cite_ref-:3_8-0" class="reference"><a href="#cite_note-:3-8">&#91;8&#93;</a></sup> A PWS is a well delineated red macule that is present at birth and gets darker and thicker with age. In addition, many small and large dark nodules can grow on the surface, resembling pyogenic granulomas.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10">&#91;10&#93;</a></sup><sup id="cite_ref-11" class="reference"><a href="#cite_note-11">&#91;11&#93;</a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12">&#91;12&#93;</a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup> 
</p><p>The PWS is typically present in the V1 and V2 distributions of the trigeminal nerve. Leptomeningeal and ocular hemangiomas are usually accompanied by PWS in the eyelids, with the upper eyelid being more frequently affected than the lower.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup> If the PWS is present bilaterally, the likelihood of having SWS is higher than when the PWS is present unilaterally. In some cases, the ipsilateral nasal and buccal mucosa may also be involved on the side of PWS.
</p><p>The distribution of PWS along various branches of the trigmenial nerve determines the severity of associated neurological deficits and associated glaucoma. Hennedige et al.<sup id="cite_ref-:3_8-1" class="reference"><a href="#cite_note-:3-8">&#91;8&#93;</a></sup> reported that patients with PWS only in the V1 dermatome had a 6.7% risk of glaucoma and 26.7% risk of neurologic manifestations. They reported no risk of glaucoma and a lower risk of neurologic manifestations, 3.1%, when only the V2 distribution was involved. When both the V1 and V2 dermatomes were involved, the risk of both glaucoma (31.8%) and neurologic manifestations (54.5%) was much higher.<sup id="cite_ref-:3_8-2" class="reference"><a href="#cite_note-:3-8">&#91;8&#93;</a></sup> They also observed that, if all three dermatomes (V1, V2, V3) were involved, the risk of neurologic manifestations quadrupled. 
</p><p>The PWS has been reported to improve with pulsed dye laser photocoagulation.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup> This laser uses thermolysis and results in irreversible damage to blood vessels but spares other components of the skin.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17">&#91;17&#93;</a></sup> Often, multiple treatments are required with minimal to no side effects. However, the patients rarely get a 100% clearance of their skin discoloration.<sup id="cite_ref-:3_8-3" class="reference"><a href="#cite_note-:3-8">&#91;8&#93;</a></sup><sup id="cite_ref-18" class="reference"><a href="#cite_note-18">&#91;18&#93;</a></sup> Central forehead stains have a better outcome than do central facial stains.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20">&#91;20&#93;</a></sup><sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup> The patients with V2 involvement tend to have the worst outcome after laser treatment. By the fifth decade of life, approximately 65% of patients will have hypertrophy and nodules within the lesions. Therefore, many psychological benefits have been reported after the laser treatment of PWS.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="Neurologic_Manifestations_and_Treatment">Neurologic Manifestations and Treatment</span></h1>
<p>The most common neurological manifestation in SWS is seizures, with partial seizures being the most common type. Seizures are present in approximately 80% of patients and usually develop during the first year of life. The seizures will manifest before the first year of age in 75% of the patients, although some patients may experience seizures for the first time as adults. Seizures will be present in 95% of patients with bilateral leptomeningeal lesions and 75% of patients with unilateral lesions.<sup id="cite_ref-:4_25-0" class="reference"><a href="#cite_note-:4-25">&#91;25&#93;</a></sup><sup id="cite_ref-:5_26-0" class="reference"><a href="#cite_note-:5-26">&#91;26&#93;</a></sup> Bilateral lesions present in 7% to 26% of cases and are usually accompanied by more severe neurological symptoms compared to unilateral lesions.<sup id="cite_ref-:2_6-1" class="reference"><a href="#cite_note-:2-6">&#91;6&#93;</a></sup><sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup> There is also an association between earlier onset of seizures and the development of other neurological manifestations such as contralateral hemiparesis, hemianopsia, hemiplegia, mental retardation, developmental delay, or behavioral problems.<sup id="cite_ref-:2_6-2" class="reference"><a href="#cite_note-:2-6">&#91;6&#93;</a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup><sup id="cite_ref-:6_30-0" class="reference"><a href="#cite_note-:6-30">&#91;30&#93;</a></sup> Developmental delay, mental retardation, and headaches occur in approximately 50% of patients with SWS.<sup id="cite_ref-:4_25-1" class="reference"><a href="#cite_note-:4-25">&#91;25&#93;</a></sup><sup id="cite_ref-:6_30-1" class="reference"><a href="#cite_note-:6-30">&#91;30&#93;</a></sup><sup id="cite_ref-31" class="reference"><a href="#cite_note-31">&#91;31&#93;</a></sup> In addition, approximately 30% of patients will be severely mentally handicapped.<sup id="cite_ref-:2_6-3" class="reference"><a href="#cite_note-:2-6">&#91;6&#93;</a></sup> However, patients with no seizures before 2 years of age will have normal intelligence and development.<sup id="cite_ref-:4_25-2" class="reference"><a href="#cite_note-:4-25">&#91;25&#93;</a></sup>
</p><p>The leptomeningeal lesions are present at birth and usually located in the occipital and parietal lobes of the meninges.8 These can be detected by magnetic resonance imaging or computed tomography.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32">&#91;32&#93;</a></sup> Even though computed tomography is very effective in detecting intracranial calcifications, these are usually not present in neonates. Therefore, the best method to diagnose the leptomeningeal lesions is magnetic resonance imaging with gadolinium contrast.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup>  
</p><p>The most important aspect in the treatment of SWS is seizure control. Management of seizures with anticonvulsant therapy has been reported to have favorable results in approximately half of the patients with SWS. Nevertheless, the majority of  patients will require more than one medication for treatment.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">&#91;34&#93;</a></sup> In cases where seizures cannot be managed with medical therapy, surgical therapy may be beneficial.<sup id="cite_ref-:7_35-0" class="reference"><a href="#cite_note-:7-35">&#91;35&#93;</a></sup><sup id="cite_ref-:8_36-0" class="reference"><a href="#cite_note-:8-36">&#91;36&#93;</a></sup><sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup> When seizures are poorly controlled and are present in only one hemisphere, hemispherectomy has been reported to have favorable results, with approximately 80% of the patients being seizure free after the procedure.<sup id="cite_ref-:7_35-1" class="reference"><a href="#cite_note-:7-35">&#91;35&#93;</a></sup><sup id="cite_ref-:8_36-1" class="reference"><a href="#cite_note-:8-36">&#91;36&#93;</a></sup><sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup><sup id="cite_ref-39" class="reference"><a href="#cite_note-39">&#91;39&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="Ocular_Manifestations_and_Treatment">Ocular Manifestations and Treatment</span></h1>
<p>Ocular manifestations of SWS include conjunctival, episcleral, and choroidal hemangiomas. Choroidal hemangiomas may be present in up to 71% of patients with SWS and may be circumscribed or diffuse.<sup id="cite_ref-:1_4-2" class="reference"><a href="#cite_note-:1-4">&#91;4&#93;</a></sup> SWS is usually associated with the diffuse variant that often presents in patients with late-onset glaucoma.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;40&#93;</a></sup> The treatment of patients with glaucoma and diffuse choroidal hemangiomas is extremely challenging and may be associated with devastating complications, such as choroidal effusions, retinal detachments, or severe hemorrhages. Since these patients are usually refractory to medical therapy, other treatment options have been used. These include radiotherapy, stereotactic radiotherapy, plaque radiotherapy, proton beam, anti-vascular endothelial growth factors, and photodynamic therapy.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">&#91;41&#93;</a></sup><sup id="cite_ref-42" class="reference"><a href="#cite_note-42">&#91;42&#93;</a></sup><sup id="cite_ref-43" class="reference"><a href="#cite_note-43">&#91;43&#93;</a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44">&#91;44&#93;</a></sup><sup id="cite_ref-45" class="reference"><a href="#cite_note-45">&#91;45&#93;</a></sup> Glaucoma is one of the most challenging ocular manifestations of SWS.
</p>
<h1><span class="mw-headline" id="Glaucoma">Glaucoma</span></h1>
<p>Glaucoma presents in 30-70% of patients with SWS.<sup id="cite_ref-:1_4-3" class="reference"><a href="#cite_note-:1-4">&#91;4&#93;</a></sup> Of the systemic hamartosis, SWS has the highest incidence of glaucoma. Approximately 60% of patients present with glaucoma at birth and 40% manifest glaucoma later in life.<sup id="cite_ref-:9_46-0" class="reference"><a href="#cite_note-:9-46">&#91;46&#93;</a></sup> The incidence of glaucoma increases when the PWS involves the eyelid.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47">&#91;47&#93;</a></sup> It presents most often ipsilateral to the PWS but can also manifest bilaterally.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48">&#91;48&#93;</a></sup>
</p><p>The two main mechanisms of glaucoma in SWS are malformation of the anterior chamber angle and an elevated episcleral venous pressure.<sup id="cite_ref-:10_49-0" class="reference"><a href="#cite_note-:10-49">&#91;49&#93;</a></sup> An abnormal anterior chamber angle has been demonstrated in enucleated eyes with SWS.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">&#91;50&#93;</a></sup> The abnormalities of the anterior chamber angle in patients with SWS resemble those seen in eyes with primary congenital glaucoma. These findings include a wider uveal meshwork, a ciliary muscle that is directly attached to the trabecular meshwork, an under-developed scleral spur, and an iris root that is inserted anteriorly. 
</p><p>When glaucoma is present at birth, it is due to a malformation of the anterior chamber angle, and patients manifest typical signs of congenital glaucoma, including buphthalmos, anisometropia, and amblyopia. When it presents later, it is usually secondary to elevated episcleral venous pressure.4,49 When gonioscopy is performed in older children and adults with SWS and glaucoma, either minimal or no angle abnormality may be present. In addition, when gonioscopy is performed in older patients, blood is usually seen in the angle, correlating with an increase in episcleral venous pressure.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51">&#91;51&#93;</a></sup> Another mechanism of glaucoma is thought to be premature aging of the trabecular meshwork that causes an early onset chronic open angle glaucoma, presenting in early adulthood. When neovascularization is present in the iris or angle, peripheral anterior synechiae may develop and result in secondary angle closure glaucoma.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52">&#91;52&#93;</a></sup>
</p><p>Managing glaucoma in patients with SWS is complex because of early onset and resistance to conventional therapy. For early onset glaucoma with associated angle abnormalities, surgical intervention is usually required, with either goniotomy or trabeculotomy.<sup id="cite_ref-:9_46-1" class="reference"><a href="#cite_note-:9-46">&#91;46&#93;</a></sup><sup id="cite_ref-:10_49-1" class="reference"><a href="#cite_note-:10-49">&#91;49&#93;</a></sup> However, the outcomes are generally worse than those observed with primary congenital glaucoma, and these cases often require additional surgery with trabeculectomy or a glaucoma drainage device. Olsen et al.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53">&#91;53&#93;</a></sup> assessed the efficacy of goniotomy and trabeculotomy in 15 eyes. They found that the intraocular pressure (IOP) was controlled in 66.7% (10/15 eyes) after one or more goniotomy or trabeculotomy procedures, with a median follow-up of 5.4 years. The range of the patients’ age was from birth to 4 years, with a mean of 11.8 months. Iwach and colleagues reported the median stable interval of IOP control after a single goniotomy or trabeculotomy to be 8 and 21 months, respectively, in patients younger than 4 years.<sup id="cite_ref-:9_46-2" class="reference"><a href="#cite_note-:9-46">&#91;46&#93;</a></sup> In a study of 6 patients who underwent trabeculectomy and were followed from 9 months to 9 years, IOP was controlled in two eyes without medical therapy and in four eyes with medical therapy. Only one patient had a repeat trabeculectomy with adjunctive medical therapy to maintain adequate IOP.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">&#91;54&#93;</a></sup> A combined trabeculotomy with trabeculectomy was assessed in 10 eyes with glaucoma associated with SWS.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">&#91;55&#93;</a></sup> All eyes maintained IOP of less than 16 mm Hg without medication during a mean postoperative follow up of 27.8 months. 
</p><p>For late onset glaucoma, medical therapy is initiated first; aqueous suppressants and miotics tend to be the most successful. Prostaglandin analogues have been reported to have inconsistent response rates. Laser trabeculoplasty appears to be of limited use. If medical therapy is ineffective, trabeculectomy remains the procedure of choice for late onset cases, because it bypasses the episcleral venous system. Outcomes of trabeculectomy may be improved with the use of antimetabolites. Of note, trabeculectomy is associated with a much higher risk of choroidal effusions or suprachoroidal hemorrhages in eyes with SWS. 
</p><p>Glaucoma drainage devices have also been shown to be effective for glaucoma secondary to SWS. Hamush et al.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup> treated 11 eyes with the Ahmed glaucoma drainage device. The cumulative probability of success was 79% at 24 months, 59% at 42 months, and 30% at 60 months. Success was defined as an IOP &lt; 21 mmHg on the last two measurements with no additional surgery or complications like hemorrhage or retinal detachments. A two-staged Baerveldt glaucoma drainage device was used in another study for the treatment of 10 eyes with SWS and glaucoma. Patients were, on average, 7 years old, and surgical success, defined as IOP&lt;21 mm Hg after an average of 35 months of follow up, was 100%.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57">&#91;57&#93;</a></sup> The two-stage technique allows encapsulation to occur around the plate for a few weeks prior to insertion of the tube into the anterior chamber, minimizing the risk of hypotomy and subsequent choroidal effusion or hemorrhage.
</p><p>Another treatment option is cyclophotocoagulation (CPC) which can be performed in patients with refractory glaucoma or in patients who are likely to have much higher risk of intraoperative or postoperative complications (choroidal expulsive hemorrhage or choroidal detachment) after glaucoma filtration surgery.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58">&#91;58&#93;</a></sup> In a study of 16 children (16 eyes) with a mean follow-up of 8.87 years in which CPC was performed, 10 eyes (62.5%) maintained an IOP between 6-22 mm Hg without any complications associated with the treatment.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">&#91;59&#93;</a></sup>
</p>
<h1><span id="Klippel-Trenaunay-Weber_Syndrome_(KTS)"></span><span class="mw-headline" id="Klippel-Trenaunay-Weber_Syndrome_.28KTS.29">Klippel-Trenaunay-Weber Syndrome (KTS)</span></h1>
<p>This syndrome, a rare cause of secondary glaucoma that should be distinguished from SWS, is characterized by a localized or diffuse capillary malformation that overlies a venous malformation and/or lymphatic malformation with associated soft tissue and bone hypertrophy.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60">&#91;60&#93;</a></sup><sup id="cite_ref-61" class="reference"><a href="#cite_note-61">&#91;61&#93;</a></sup> In addition to the extensive cutaneous hemangiomas affecting the face, similar to SWS, the trunk and limbs are involved. Dysplastic veins and hypertrophy of bone and soft tissues are often present in the affected extremity, a lower limb in 90% of the patients. Malformations of deep veins increase the risk of deep vein thrombosis and pulmonary embolism. Visceral organ involvement is associated with greater morbidity secondary to internal hemorrhage. Cerebral hemangiomas may also occur, causing epilepsy and mental retardation.
</p>
<h1><span class="mw-headline" id="Prognosis">Prognosis</span></h1>
<p>Patients with SWS have a lower life expectancy than does  the general population.<sup id="cite_ref-:5_26-1" class="reference"><a href="#cite_note-:5-26">&#91;26&#93;</a></sup> When the leptomeningeal lesions are bilateral, patients usually have more severe neurological manifestations and a worse prognosis. 
</p>
<h1><span class="mw-headline" id="Summary">Summary</span></h1>
<p>SWS is a rare, sporadic disorder with glaucoma being the most common ocular manifestation. Treatment of glaucoma requires an understanding of underlying pathology and mechanisms to guide appropriate surgical intervention. In general, lower surgical success and increased intraoperative and postoperative complications are observed in these patients when compared to other types of glaucomas. Several precautionary steps can be taken to minimize these complications, including preoperative reduction of IOP with hyperosmotic agents, placement of posterior sclerotomies prior to entering the eye, preplacement of flap sutures or additional and tight sutures during trabeculectomy, use of valved or two-stage glaucoma drainage devices, or radiotherapy of choroidal hemangiomas prior to intraocular surgery. Because multiple organs are involved in SWS, a multidisciplinary approach is recommended to deliver comprehensive care and optimize overall outcomes.
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><a href="#cite_ref-1">↑</a></span> <span class="reference-text">Comi AM. Presentation, diagnosis, pathophysiology, and
treatment of the neurological features of Sturge-Weber syndrome. Neurologist
2011;17:179-84.</span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><a href="#cite_ref-2">↑</a></span> <span class="reference-text">Schirmer. Ein Fall von Teleangiektasie: Archives of
ophthalmology, 1860:119-121.</span>
</li>
<li id="cite_note-:0-3"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:0_3-0">3.0</a></sup> <sup><a href="#cite_ref-:0_3-1">3.1</a></sup></span> <span class="reference-text">Thomas-Sohl KA, Vaslow DF, Maria BL. Sturge-Weber
syndrome: a review. Pediatr Neurol 2004;30:303-10.</span>
</li>
<li id="cite_note-:1-4"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:1_4-0">4.0</a></sup> <sup><a href="#cite_ref-:1_4-1">4.1</a></sup> <sup><a href="#cite_ref-:1_4-2">4.2</a></sup> <sup><a href="#cite_ref-:1_4-3">4.3</a></sup></span> <span class="reference-text">Sullivan TJ, Clarke MP, Morin JD. The ocular manifestations of the Sturge-Weber syndrome. J Pediatr Ophthalmol Strabismus 1992;29:349-56.</span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><a href="#cite_ref-5">↑</a></span> <span class="reference-text">Awad AH, Mullaney PB, Al-Mesfer S, et al. Glaucoma in
Sturge-Weber syndrome. J AAPOS 1999;3:40-5.</span>
</li>
<li id="cite_note-:2-6"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:2_6-0">6.0</a></sup> <sup><a href="#cite_ref-:2_6-1">6.1</a></sup> <sup><a href="#cite_ref-:2_6-2">6.2</a></sup> <sup><a href="#cite_ref-:2_6-3">6.3</a></sup></span> <span class="reference-text">Pascual-Castroviejo I, Díaz-Gonzalez C, García-Melian RM, et
al. Sturge-Weber
syndrome: study of 40 patients. Pediatr Neurol 1993;9:283-8.</span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><a href="#cite_ref-7">↑</a></span> <span class="reference-text">Jacobs AH, Walton RG. The incidence of birthmarks in the
neonate. Pediatrics 1976;58:218-22.</span>
</li>
<li id="cite_note-:3-8"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:3_8-0">8.0</a></sup> <sup><a href="#cite_ref-:3_8-1">8.1</a></sup> <sup><a href="#cite_ref-:3_8-2">8.2</a></sup> <sup><a href="#cite_ref-:3_8-3">8.3</a></sup></span> <span class="reference-text">Hennedige AA, Quaba AA, Al-Nakib K. Sturge-Weber syndrome and
dermatomal facial port-wine stains: incidence, association with glaucoma, and
pulsed tunable dye laser treatment effectiveness. Plast Reconstr Surg
2008;121:1173-80.</span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><a href="#cite_ref-9">↑</a></span> <span class="reference-text">Lee JB, Kim M, Lee SC, et al. Granuloma pyogenicum
arising in an arteriovenous haemangioma associated with a port-wine stain. Br J
Dermatol 2000;143:669-71.</span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><a href="#cite_ref-10">↑</a></span> <span class="reference-text">Kim TH, Choi EH, Ahn SK, et al. Vascular tumors arising in port-wine stains: two cases of pyogenic granuloma and a case of acquired tufted angioma. J Dermatol 1999;26:813-6.</span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><a href="#cite_ref-11">↑</a></span> <span class="reference-text">Carrasco L, Pastor A, Fariña C, et al. Acral arteriovenous tumor developed within a nevus flammeus in a patient with Sturge-Weber syndrome. Am J Dermatopathol 2003;25:341-5.</span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><a href="#cite_ref-12">↑</a></span> <span class="reference-text">Castanedo-Cazares JP, Lepe V, Moncada B. Pyogenic granuloma within port-wine stains. Eur J Dermatol 2002;12:616.</span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><a href="#cite_ref-13">↑</a></span> <span class="reference-text">Valeyrie L, Lebrun-Vignes B, Descamps V, et al. Pyogenic granuloma within port-wine stains: an alarming clinical presentation. Eur J Dermatol 2002;12:373-5.</span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><a href="#cite_ref-14">↑</a></span> <span class="reference-text">Tallman B, Tan OT, Morelli JG, et al. Location of port-wine
stains and the likelihood of ophthalmic and/or central nervous system
complications. Pediatrics 1991;87:323-7.</span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><a href="#cite_ref-15">↑</a></span> <span class="reference-text">Rosen S, Smoller B. Pathogenesis of port wine stains. A
new hypothesis. Med Hypotheses 1987;22:365-8.</span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><a href="#cite_ref-16">↑</a></span> <span class="reference-text">Smoller BR, Rosen S. Port-wine stains. A disease of altered neural modulation of blood vessels? Arch Dermatol 1986;122:177-9.</span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><a href="#cite_ref-17">↑</a></span> <span class="reference-text">Scherer K, Lorenz S, Wimmershoff M, et al. Both the flashlamp-pumped dye laser and the long-pulsed tunable dye laser can improve results in port-wine stain therapy. Br J Dermatol 2001;145:79-84.</span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><a href="#cite_ref-18">↑</a></span> <span class="reference-text">Léauté-Labréze C, Boralevi F, Pedespan JM, et al. Pulsed dye laser for Sturge-Weber syndrome. Arch Dis Child 2002;87:434-5.</span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><a href="#cite_ref-19">↑</a></span> <span class="reference-text">Fitzpatrick RE, Lowe NJ, Goldman MP, et al.
Flashlamp-pumped pulsed dye laser treatment of port-wine stains. J Dermatol
Surg Oncol 1994;20:743-8.</span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><a href="#cite_ref-20">↑</a></span> <span class="reference-text">Morelli JG, Weston WL, Huff JC, et al. Initial lesion size as a predictive factor in determining the response of port-wine stains in children treated with the pulsed dye laser. Arch Pediatr Adolesc Med 1995;149:1142-4.</span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><a href="#cite_ref-21">↑</a></span> <span class="reference-text">Nguyen CM, Yohn JJ, Huff C, et al. Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the number of treatments with the pulsed dye (585 nm) laser. Br J Dermatol 1998;138:821-5.</span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><a href="#cite_ref-22">↑</a></span> <span class="reference-text">Renfro L, Geronemus RG. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol 1993;129:182-8.</span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><a href="#cite_ref-23">↑</a></span> <span class="reference-text">Batta K. Management of large birthmarks. Semin Neonatol 2000;5:325-32.</span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><a href="#cite_ref-24">↑</a></span> <span class="reference-text">Geronemus RG, Ashinoff R. The medical necessity of evaluation
and treatment of port-wine stains. J Dermatol Surg Oncol 1991;17:76-9.</span>
</li>
<li id="cite_note-:4-25"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:4_25-0">25.0</a></sup> <sup><a href="#cite_ref-:4_25-1">25.1</a></sup> <sup><a href="#cite_ref-:4_25-2">25.2</a></sup></span> <span class="reference-text">Sujansky E, Conradi S. Outcome of Sturge-Weber syndrome
in 52 adults. Am J Med Genet 1995;57:35-45.</span>
</li>
<li id="cite_note-:5-26"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:5_26-0">26.0</a></sup> <sup><a href="#cite_ref-:5_26-1">26.1</a></sup></span> <span class="reference-text">Oakes WJ. The natural history of patients with the Sturge-Weber syndrome. Pediatr Neurosurg 1992;18:287-90.</span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><a href="#cite_ref-27">↑</a></span> <span class="reference-text">Griffiths PD, Boodram MB, Blaser S, et al. Abnormal ocular enhancement in Sturge-Weber syndrome: correlation of ocular MR and CT findings with clinical and intracranial imaging findings. AJNR Am J Neuroradiol 1996;17:749-54.</span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><a href="#cite_ref-28">↑</a></span> <span class="reference-text">Kramer U, Kahana E, Shorer Z, Ben-Zeev B. Outcome of
infants with unilateral Sturge-Weber syndrome and early onset seizures. Dev Med
Child Neurol 2000;42:756-9.</span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><a href="#cite_ref-29">↑</a></span> <span class="reference-text">JB B. Sturge-Weber Syndrome. In: Vascular Birthmarks of the Head and Neck, Hochman M (Ed), Facial Plastic Surgery Clinics of North America, 2001:569.</span>
</li>
<li id="cite_note-:6-30"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:6_30-0">30.0</a></sup> <sup><a href="#cite_ref-:6_30-1">30.1</a></sup></span> <span class="reference-text">Sujansky E, Conradi S. Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol 1995;10:49-58.</span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><a href="#cite_ref-31">↑</a></span> <span class="reference-text">Klapper J. Headache in Sturge-Weber syndrome. Headache 1994;34:521-2.</span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><a href="#cite_ref-32">↑</a></span> <span class="reference-text">Martí-Bonmatí L, Menor F,
Poyatos C, et al. Diagnosis of Sturge-Weber syndrome: comparison of the
efficacy of CT and MR imaging in 14 cases. AJR Am J Roentgenol 1992;158:867-71.</span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><a href="#cite_ref-33">↑</a></span> <span class="reference-text">Truhan AP, Filipek PA. Magnetic resonance imaging. Its role in the neuroradiologic evaluation of neurofibromatosis, tuberous sclerosis, and Sturge-Weber syndrome. Arch Dermatol 1993;129:219-26.</span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><a href="#cite_ref-34">↑</a></span> <span class="reference-text">Arzimanoglou A, Aicardi J. The epilepsy of Sturge-Weber syndrome: clinical features and treatment in 23 patients. Acta Neurol Scand Suppl 1992;140:18-22.</span>
</li>
<li id="cite_note-:7-35"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:7_35-0">35.0</a></sup> <sup><a href="#cite_ref-:7_35-1">35.1</a></sup></span> <span class="reference-text">Arzimanoglou AA, Andermann F, Aicardi J, et al. Sturge-Weber syndrome: indications and results of surgery in 20 patients. Neurology 2000;55:1472-9.</span>
</li>
<li id="cite_note-:8-36"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:8_36-0">36.0</a></sup> <sup><a href="#cite_ref-:8_36-1">36.1</a></sup></span> <span class="reference-text">Kossoff EH, Buck C, Freeman JM. Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwide. Neurology 2002;59:1735-8.</span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><a href="#cite_ref-37">↑</a></span> <span class="reference-text">Bourgeois M, Crimmins DW, de Oliveira RS, et al.
Surgical treatment of epilepsy in Sturge-Weber syndrome in children. J
Neurosurg 2007;106:20-8.</span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><a href="#cite_ref-38">↑</a></span> <span class="reference-text">Ito M, Sato K, Ohnuki A, Uto A. Sturge-Weber disease: operative indications and surgical results. Brain Dev 1990;12:473-7.</span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><a href="#cite_ref-39">↑</a></span> <span class="reference-text">Tuxhorn IE, Pannek HW. Epilepsy surgery in bilateral Sturge-Weber syndrome. Pediatr Neurol 2002;26:394-7.</span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><a href="#cite_ref-40">↑</a></span> <span class="reference-text">Celebi S, Alagöz G, Aykan U. Ocular findings in
Sturge-Weber syndrome. Eur J Ophthalmol 2000;10:239-43.</span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><a href="#cite_ref-41">↑</a></span> <span class="reference-text">Zografos L, Bercher L, Egger E, et al. [Treatment of eye tumors by accelerated proton beams. 7 years experience]. Klin Monbl Augenheilkd 1992;200:431-5.</span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><a href="#cite_ref-42">↑</a></span> <span class="reference-text">Zografos L, Bercher L, Chamot L, et al. Cobalt-60 treatment of choroidal hemangiomas. Am J Ophthalmol 1996;121:190-9.</span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><a href="#cite_ref-43">↑</a></span> <span class="reference-text">Sagong M, Lee J, Chang W. Application of intravitreal bevacizumab for circumscribed choroidal hemangioma. Korean J Ophthalmol 2009;23:127-31.</span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><a href="#cite_ref-44">↑</a></span> <span class="reference-text">Anand R. Photodynamic therapy for diffuse choroidal hemangioma associated with Sturge Weber syndrome. Am J Ophthalmol 2003;136:758-60.</span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><a href="#cite_ref-45">↑</a></span> <span class="reference-text">Bains HS, Cirino AC, Ticho BH, et al. Photodynamic therapy using verteporfin for a diffuse choroidal hemangioma in Sturge-Weber syndrome. Retina 2004;24:152-5.</span>
</li>
<li id="cite_note-:9-46"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:9_46-0">46.0</a></sup> <sup><a href="#cite_ref-:9_46-1">46.1</a></sup> <sup><a href="#cite_ref-:9_46-2">46.2</a></sup></span> <span class="reference-text">Iwach AG, Hoskins HD, Hetherington J, et al. Analysis
of surgical and medical management of glaucoma in Sturge-Weber syndrome.
Ophthalmology 1990;97:904-9.</span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><a href="#cite_ref-47">↑</a></span> <span class="reference-text">van Emelen C, Goethals M, Dralands L, et al. Treatment of glaucoma in children with Sturge-Weber syndrome. J Pediatr Ophthalmol Strabismus 2000;37:29-34.</span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><a href="#cite_ref-48">↑</a></span> <span class="reference-text">Amirikia A, Scott IU, Murray TG. Bilateral diffuse choroidal hemangiomas with unilateral facial nevus flammeus in Sturge-Weber syndrome. Am J Ophthalmol 2000;130:362-4.</span>
</li>
<li id="cite_note-:10-49"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:10_49-0">49.0</a></sup> <sup><a href="#cite_ref-:10_49-1">49.1</a></sup></span> <span class="reference-text">Weiss DI. Dual origin of glaucoma in encephalotrigeminal haemangiomatosis. Trans Ophthalmol Soc U K 1973;93:477-93.</span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><a href="#cite_ref-50">↑</a></span> <span class="reference-text">Cibis GW, Tripathi RC, Tripathi BJ. Glaucoma in Sturge-Weber syndrome. Ophthalmology 1984;91:1061-71.</span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><a href="#cite_ref-51">↑</a></span> <span class="reference-text">Phelps CD. The pathogenesis of glaucoma in Sturge-Weber syndrome. Ophthalmology 1978;85:276-86.</span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><a href="#cite_ref-52">↑</a></span> <span class="reference-text">Nelson LB CJ, Harley RD. Pediatric ophthalmology 3rd ed. Philadelphia: WB Saunders, 1991:p. 437-40.</span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><a href="#cite_ref-53">↑</a></span> <span class="reference-text">Karl E. Olsen ASH, and Martha M. Wright. The Efficacy of Goniotomy/Trabeculotomy in Early-Onset Glaucoma Associated With the Sturge- Weber Syndrome: AAPOS, 1999.</span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><a href="#cite_ref-54">↑</a></span> <span class="reference-text">Ali MA, Fahmy IA, Spaeth GL. Trabeculectomy for glaucoma associated with Sturge-Weber syndrome. Ophthalmic Surg 1990;21:352-5.</span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><a href="#cite_ref-55">↑</a></span> <span class="reference-text">Mandal AK. Primary combined trabeculotomy-trabeculectomy for early-onset glaucoma in Sturge-Weber syndrome. Ophthalmology 1999;106:1621-7.</span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><a href="#cite_ref-56">↑</a></span> <span class="reference-text">Hamush NG, Coleman AL, Wilson MR. Ahmed glaucoma valve implant for management of glaucoma in Sturge-Weber syndrome. Am J Ophthalmol 1999;128:758-60.</span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><a href="#cite_ref-57">↑</a></span> <span class="reference-text">Budenz DL, Sakamoto D, Eliezer R, et al. Two-staged Baerveldt glaucoma implant for childhood glaucoma associated with Sturge-Weber syndrome. Ophthalmology 2000;107:2105-10.</span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><a href="#cite_ref-58">↑</a></span> <span class="reference-text">Agarwal HC, Sandramouli S, Sihota R, et al. Sturge-Weber syndrome: management of glaucoma with combined trabeculotomy-trabeculectomy. Ophthalmic Surg 1993;24:399-402.</span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><a href="#cite_ref-59">↑</a></span> <span class="reference-text">Kocyła-Karczmarewicz B, Klimczak-Slaczka D, Grałek M, et al. [Childhood glaucoma associated with Sturge-Weber syndrome --the efficacy of cyclofotocoagulation and other therapeutic methods]. Klin Oczna 2006;108:180-3.</span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><a href="#cite_ref-60">↑</a></span> <span class="reference-text">Purkait R, Samanta T, Sinhamahapatra T, et al. Overlap of sturge-weber syndrome and klippel-trenaunay syndrome. Indian J Dermatol 2011;56:755-7.</span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><a href="#cite_ref-61">↑</a></span> <span class="reference-text">Rahman M, Rahman S, Akhter S, et al. Overlapping of Sturge Weber syndrome and Klippel Trenaunay Weber syndrome. Mymensingh Med J 2008;17:78-81.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035202
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.002 seconds
CPU time usage: 0.284 seconds
Real time usage: 0.769 seconds
Preprocessor visited node count: 1027/1000000
Post‐expand include size: 4581/2097152 bytes
Template argument size: 893/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 25215/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  328.675      1 Template:Article
100.00%  328.675      1 -total
 82.03%  269.617      4 Template:Infobox_section
 19.10%   62.784      3 Template:UserLookup
  4.81%   15.799      1 Template:Review_expired
  3.16%   10.390      1 Template:Infobox_end
  1.57%    5.160      1 Template:Infobox_begin
  0.41%    1.345      1 Template:Get_active_contest
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;oldid=87694">https://eyewiki.org/w/index.php?title=Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;oldid=87694</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzz0et6c">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Sturge-Weber_Syndrome_and_Secondary_Glaucoma" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Sturge-Weber_Syndrome_and_Secondary_Glaucoma" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;oldid=87694" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Sturge-Weber_Syndrome_and_Secondary_Glaucoma&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on December 25, 2022, at 17:02.</div>
					<div>This page has been accessed 102,948 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.002},"limitreport":{"cputime":"0.284","walltime":"0.769","ppvisitednodes":{"value":1027,"limit":1000000},"postexpandincludesize":{"value":4581,"limit":2097152},"templateargumentsize":{"value":893,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":25215,"limit":5000000},"timingprofile":["100.00%  328.675      1 Template:Article","100.00%  328.675      1 -total"," 82.03%  269.617      4 Template:Infobox_section"," 19.10%   62.784      3 Template:UserLookup","  4.81%   15.799      1 Template:Review_expired","  3.16%   10.390      1 Template:Infobox_end","  1.57%    5.160      1 Template:Infobox_begin","  0.41%    1.345      1 Template:Get_active_contest"]},"cachereport":{"timestamp":"20230306035202","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":1234});});</script></body>
</html>